Detalles de la búsqueda
1.
The biological and clinical impact of deletions before and after large chromosomal gains in multiple myeloma.
Blood
; 2024 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38728430
2.
Long-term outcomes and renal responses following autologous hematopoietic stem cell transplantation for light chain deposition disease: a retrospective study on behalf of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.
Haematologica
; 2024 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38546696
3.
Widespread amyloidogenicity potential of multiple myeloma patient-derived immunoglobulin light chains.
BMC Biol
; 21(1): 21, 2023 02 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36737754
4.
Impact of newly diagnosed extramedullary myeloma on outcome after first autograft followed by maintenance: A CMWP-EBMT study.
Eur J Haematol
; 111(2): 181-190, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37082839
5.
18F-FDG-PET/CT in relapsed multiple myeloma: Are prognostic thresholds different from first-line therapy?
BMC Med Imaging
; 22(1): 63, 2022 04 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35379187
6.
De Novo Sequencing of Antibody Light Chain Proteoforms from Patients with Multiple Myeloma.
Anal Chem
; 93(30): 10627-10634, 2021 08 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34292722
7.
Tandem Autologous Stem Cell Transplantation Improves Outcomes in Newly Diagnosed Multiple Myeloma with Extramedullary Disease and High-Risk Cytogenetics: A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 25(11): 2134-2142, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31288095
8.
Rationale and design of the German-speaking myeloma multicenter group (GMMG) trial HD6: a randomized phase III trial on the effect of elotuzumab in VRD induction/consolidation and lenalidomide maintenance in patients with newly diagnosed myeloma.
BMC Cancer
; 19(1): 504, 2019 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-31138244
9.
Relapse patterns and treatment strategies in patients receiving allogeneic hematopoietic stem cell transplantation for myeloid malignancies.
Ann Hematol
; 98(5): 1225-1235, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30923997
10.
Interaction of increasing ICU survival and admittance policies in patients with hematologic neoplasms: A single center experience with 304 patients.
Eur J Haematol
; 102(3): 265-274, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30578742
11.
Prognostic value of circulating Bcl-2/IgH levels in patients with follicular lymphoma receiving first-line immunochemotherapy.
Blood
; 126(12): 1407-14, 2015 Sep 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-26239087
12.
Cyclophosphamide-based stem cell mobilization in relapsed multiple myeloma patients: A subgroup analysis from the phase III trial ReLApsE.
Eur J Haematol
; 99(1): 42-50, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28370401
13.
Lenalidomide consolidation treatment in patients with multiple myeloma suppresses myelopoieses but spares erythropoiesis.
Int J Cancer
; 139(10): 2343-52, 2016 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27389073
14.
Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE: a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients with relapsed multiple myeloma.
BMC Cancer
; 16: 290, 2016 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-27114074
15.
Treatment of acute myeloid leukemia or myelodysplastic syndrome relapse after allogeneic stem cell transplantation with azacitidine and donor lymphocyte infusions--a retrospective multicenter analysis from the German Cooperative Transplant Study Group.
Biol Blood Marrow Transplant
; 21(4): 653-60, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25540937
16.
Multiple myeloma-related deregulation of bone marrow-derived CD34(+) hematopoietic stem and progenitor cells.
Blood
; 120(13): 2620-30, 2012 Sep 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-22517906
17.
Sequence diversity of kappa light chains from patients with AL amyloidosis and multiple myeloma.
Amyloid
; 31(2): 86-94, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38206120
18.
Stromal alterations in patients with monoclonal gammopathy of undetermined significance, smoldering myeloma, and multiple myeloma.
Blood Adv
; 8(10): 2575-2588, 2024 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38241490
19.
Predictors of early morbidity and mortality in newly diagnosed multiple myeloma: data from five randomized, controlled, phase III trials in 3700 patients.
Leukemia
; 38(3): 640-647, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38062124
20.
Genomic Classification and Individualized Prognosis in Multiple Myeloma.
J Clin Oncol
; 42(11): 1229-1240, 2024 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38194610